In support of the Rome Declaration on responsible research and innovation

After yesterday's publication of the results of the Research Excellent Framework (#REF2014) comes the post-mortem, introspection and then inevitable debate about REF2020. We will have to wait a wee while before we learn more about the impact assessment aspect of #REF2014 and the overall story it tells us about how research in higher education instiutions... Continue Reading →

GSK’s Witty remarks are easy to swallow from a patient perspective but the rest of the flock must follow

I spoke at the Clinical Discovery 2012 conference yesterday about the future value and impact of clinical research.  This is one of a number of similar events I've presented at over the last month or so.  On reflection there generally seems a more 'upbeat' conversation among conference-goers about clinical research in the UK compared to this time last... Continue Reading →

The public interest argument must extend beyond open access…here’s a sort of lay summary

Good Guardian blog yesterday giving a lay summary of the 'open access' debate vis a vis papers published in scientific journals.  There's also been a healthy exchange of letters in The Times this week but ironically that's behind their paywall.  However, at least The Times is available in all good newsagents at a reasonable price. Unsurprisingly, I... Continue Reading →

There was an online discussion hosted by The Guardian this morning about commercially sponsored clinical trials in the NHS.  You can get the jist here.

Are you researchy?

The NHS Future Forum - the recently announced exercise by the Department of Health to get the NHS reforms back on track - has today published a list of its members.  Further names are likely to be added it seems.  It includes a few 'researchy' people as we tend to call them here in the office... Continue Reading →

Blog at WordPress.com.

Up ↑

%d bloggers like this: